Impact of aging on immune-related adverse events generated by anti–programmed death (ligand)PD-(L)1 therapies
Capucine Baldini, P. Martin Romano, Anne-Laure Voisin, François‐Xavier Danlos, Stéphane Champiat, Salim Laghouati, Maria Kfoury, H. Vincent, Sophie Postel‐Vinay, Andreea Varga, Perrine Vuagnat, Vincent Ribrag, Laura Mezquita, Benjamin Besse, Antoine Hollebecque, Olivier Lambotte, Jean‐Marie Michot, Jean‐Charles Soria, Christophe Massard, Aurélien Marabelle
Topics & Concepts
Adverse effectImmune systemProgrammed cell death 1MedicineLigand (biochemistry)ImmunologyPD-L1PharmacologyInternal medicineImmunotherapyReceptorCancer Immunotherapy and BiomarkersCAR-T cell therapy researchMultiple and Secondary Primary Cancers